Report : North America Brain Aneurysm Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Surgery, Medication); Condition (Unruptured Aneurysm, Ruptured Aneurysm); End User (Hospitals, Clinics), and Geography
Surgery Segment to Grow at Faster Pace during Forecast Period
According to the latest study on "North America Brain Aneurysm Treatment Market to 2027 - Analysis and Forecast by Type, Condition, and End User", the North America brain aneurysm treatment market was valued at US$ 680.71 million in 2019 and is projected to reach US$ 1,978.12 million by 2027; it is expected to grow at a CAGR of 14.4% during 2020–2027. The report highlights trends prevailing in the North America brain aneurysm treatment market and the factors driving market along with those that act as hindrances.
Based on type, the North America brain aneurysm treatment market is segmented into surgery and medication. The medication segment held a largest share of the market in 2019. However, the surgery segment is estimated to register a higher CAGR during the forecast period owing to increasing advancements in procedures.
The North America brain aneurysm treatment market is expected to grow the growth of market is attributed to the increasing incidences of the neurological disorders such as stroke and brain aneurysms across North America. On the other hand, the high cost of procedure limits the growth of market in this region.
Stryker Corporation, MicroPort Scientific Corporation, Terumo Corporation, Penumbra, Inc and Medtronic are among the leading companies operating in the North America brain aneurysm treatment market.
The report segments North America brain aneurysm treatment Market as follows: